Your browser doesn't support javascript.
loading
A unique case of refractory primary mediastinal B-cell lymphoma with JAK3 mutation and the role for targeted therapy.
Hanna, Diane M T; Fellowes, Andrew; Vedururu, Ravikiran; Mechinaud, Francoise; Hansford, Jordan R.
Affiliation
  • Hanna DM; Children's Cancer Centre, Royal Children's Hospital, Victoria, Australia.
  • Fellowes A; Molecular Pathology Laboratory, Peter MacCallum Cancer Centre, Victoria, Australia.
  • Vedururu R; Molecular Pathology Laboratory, Peter MacCallum Cancer Centre, Victoria, Australia.
  • Mechinaud F; Children's Cancer Centre, Royal Children's Hospital, Victoria, Australia.
  • Hansford JR; Children's Cancer Centre, Royal Children's Hospital, Victoria, Australia jordan.hansford@rch.org.au.
Haematologica ; 99(9): e156-8, 2014 Sep.
Article in En | MEDLINE | ID: mdl-24837469

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Pyrimidines / Pyrroles / Gene Expression Regulation, Neoplastic / Lymphoma, Large B-Cell, Diffuse / Protein Kinase Inhibitors / Janus Kinase 3 / Mediastinal Neoplasms Limits: Adolescent / Female / Humans Language: En Journal: Haematologica Year: 2014 Document type: Article Affiliation country: Australia Country of publication: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Pyrimidines / Pyrroles / Gene Expression Regulation, Neoplastic / Lymphoma, Large B-Cell, Diffuse / Protein Kinase Inhibitors / Janus Kinase 3 / Mediastinal Neoplasms Limits: Adolescent / Female / Humans Language: En Journal: Haematologica Year: 2014 Document type: Article Affiliation country: Australia Country of publication: Italy